Latest News

KDM1 may represent a new therapeutic target for glioma

Researchers have generated preclinical data demonstrating that the protein KDM1, which functions as a lysine demethylase, is a potential target for glioma treatment, according to new research.
View full story

Post your comment.


  • Bioart: An introduction

  • Food odors activate impulse area of the brain in obese children

  • 'Connector hubs' are the champions of brain coordination

  • Sharing economy can help financial struggles

  • 'Sport shoppers' bargain hunt simply for the thrill of it, new research finds

  • Immune-disorder treatment in mice holds potential for multiple sclerosis patients

  • People who rely on their intuition are, at times, less likely to cheat

  • Mental health risk for new dads

  • Republicans prefer politicians with deep voices

  • Complex humor is no laughing matter